William A. Rees
Amgen (United States)(US)Horizon Therapeutics (United Kingdom)(IE)Horizon Therapeutics (United States)(US)
Publications by Year
Research Areas
Multiple Sclerosis Research Studies, Monoclonal and Polyclonal Antibodies Research, T-cell and B-cell Immunology, Peripheral Neuropathies and Disorders, Immunotherapy and Immune Responses
Most-Cited Works
- → T Cells Compete for Access to Antigen-Bearing Antigen-Presenting Cells(2000)411 cited
- → Tezepelumab, an anti–thymic stromal lymphopoietin monoclonal antibody, in the treatment of moderate to severe atopic dermatitis: A randomized phase 2a clinical trial(2018)314 cited
- → Betaine can eliminate the base pair composition dependence of DNA melting(1993)289 cited
- → Efficacy and Safety of MEDI2070, an Antibody Against Interleukin 23, in Patients With Moderate to Severe Crohn’s Disease: A Phase 2a Study(2017)274 cited
- → An inverse relationship between T cell receptor affinity and antigen dose during CD4+T cell responsesin vivoandin vitro(1999)263 cited
- → Activation changes the spectrum but not the diversity of genes expressed by T cells(1999)221 cited